Oppenheimer & CO Inc Pulse Biosciences, Inc. Transaction History
Oppenheimer & CO Inc
- $6.43 Billion
- Q1 2025
A detailed history of Oppenheimer & CO Inc transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 12,850 shares of PLSE stock, worth $222,176. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,850
Previous 17,850
28.01%
Holding current value
$222,176
Previous $329,000
37.39%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding PLSE
# of Institutions
87Shares Held
5.52MCall Options Held
76.1KPut Options Held
60.8K-
Black Rock Inc. New York, NY1.15MShares$19.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA843KShares$14.6 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC778KShares$13.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA466KShares$8.05 Million0.0% of portfolio
-
State Street Corp Boston, MA419KShares$7.25 Million0.0% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $642M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...